Independent LTC Pharmacy Advocacy Group Urges Stronger Effort on PDP Transparency in Response to CMS Draft 2017 Medicare Part D Call Letter

In response to the Centers for Medicare and Medicaid Service’s (CMS) draft 2017 Part D Call letter, the Senior Care Pharmacy Coalition (SCPC) urged still more rigorous efforts to ensure greater prescription drug plan (PDP) transparency in regard to Maximum Allowable Cost (MAC) pricing – despite a recent CMS initiative to do so…Read More

SCPC Comments on the CMS Draft 2017 Medicare Part D Call Letter

The Senior Care Pharmacy Coalition (“SCPC”) appreciates the opportunity to provide the following comments to the Center for Medicare and Medicaid Service’s (“CMS”) draft 2017 Part D Call Letter, dated February 19, 2016 (the “Call Letter”)….Read More

SCPC Praises Bipartisan Collins-Loebsack Letter Advancing Investigation of PBMs’ Anti-Competitive, Non-Transparent Pricing Practices

The Senior Care Pharmacy Coalition (SCPC) today praised U.S. Reps. Doug Collins (R-GA) and Dave Loebsack (D-IA) for issuing a letter with fourteen colleagues urging the Chairmen of the U.S. House Energy and Commerce, Ways and Means and Armed Services Committees to examine the importance of passing the MAC Transparency Act (H.R. 244) in advancing payment transparency in regard to how Pharmacy Benefit Managers (PBMs) reimburse a variety of pharmacy groups, including LTC pharmacies, for generic drugs administered to patients…Read More

As Shkreli Puts Face on Drug Pricing Abuses, PBM Reimbursement Trends Analysis Prompts Long-Term Care Pharmacy Group to Call for Increased 2016 Congressional Investigation

Washington, DC — With former Turing Pharmaceuticals CEO Martin Shkreli significantly raising the public profile of prescription drug pricing abuses, the Senior Care Pharmacy Coalition (SCPC) is stepping up its criticism of anti-competitive pharmacy benefit manager (PBM) pricing practices by pointing to Avalere Health pharmacy data, which SCPC argues demonstrates PBMs’ pricing methodology leads to arbitrary and capricious reimbursement – warranting greater Congressional scrutiny and oversight in 2016…Read More

Senior Care Pharmacy Coalition (SCPC) Commends Oversight & Government Reform Committee Leaders for Examining Drug Pricing Practices

The Senior Care Pharmacy Coalition (SCPC) today commended House Oversight and Government Reform Committee Chairman Jason Chaffetz (R-UT) and Ranking Member Elijah Cummings (D-MD) for holding today’s hearing, “Developments in the Prescription Drug Market,” to examine exorbitant drug price increases and growing questions about abusive pharmacy benefit manager (PBM) pricing practices…Read More

New SCPC Letter to Grassley, Leahy Urges Support For “Ensuring Patient Access and Effective Drug Enforcement Act of 2015” (S. 483)

In a new letter to Senate Judiciary Committee Chairman Charles Grassley (R-IA) and Ranking Member Patrick Leahy (D-VT), the Senior Care Pharmacy Coalition (SCPC) urged support without amendment for the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (S. 483), introduced by U.S. Senators Orrin Hatch (R-UT) and Sheldon Whitehouse (D-RI)…Read More

Follow-Up To Long-Term Care Pharmacy Listening Session

The Senior Care Pharmacy Coalition (SCPC), one of the organizations that participated in the Food and Drug Administration’s (FDA) August 26, 2015 “listening session” on long-term care (LTC) pharmacy (the Listening Session), submits the following supplemental information that FDA requested to further elucidate LTC pharmacy issues and the potential impacts of FDA’s Draft Repackaging Guidance on LTC patient care…Read More

Comments on EPA Proposed Rule: Management Standards for Hazardous Waste Pharmaceuticals

We support efforts to ensure proper handling of hazardous waste pharmaceuticals (HWP) in the long- term care (LTC) setting. Our members are committed to take all reasonable steps to ensure the safety of the LTC residents that we serve and to protect the environment…Read More

New Avalere Health Study Reveals Substantial Variation in PDP/PBM Reimbursements for Most Commonly Prescribed Drugs in Long Term Care Settings

Washington, DC – Amid growing scrutiny of Pharmacy Benefit Manager (PBM) pricing practices, along with increasing concern from Congress, regulators and consumer groups about the rapid pace and broader implications of U.S. health sector mergers and consolidations, the Senior Care Pharmacy Coalition (SCPC) today released a new analysis of long term care (LTC) pharmacy transaction data…Read More

New Avalere Health Study Details Stark Differences Between LTC and Retail Pharmacies

Washington, DC – Continuing its focus on America’s growing long term care (LTC) pharmacy sector as detailed by a new Avalere Health study, “Long-Term Care Pharmacy: The Evolving Marketplace and Emerging Policy Issues,” the Senior Care Pharmacy Coalition (SCPC) today spotlighted the major differences between LTC pharmacies and more commonly known retail pharmacies…Read More

Twitter   LinkedIn